Company Profile
Centessa Pharmaceuticals Stock Price, News & Catalysts
- Ticker:
- CNTA
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United Kingdom
Stock performance
40.50 USD (+0.80%)
Close
Last updated: June 23, 2026
6.17B USD
Market cap
Why the stock is moving
Current closing-price context is not available for CNTA.
Company overview
Business overview
Centessa Pharmaceuticals is a platform biopharma company incubating focused therapeutic programs across multiple disease areas. Its model emphasizes capital allocation, program selection, and broad platform optionality.
Geographic Base and Sector Classification
Headquartered in the United Kingdom and listed on NASDAQ as an ADR, Centessa has a global specialty-biopharma profile.
Business Model Characteristics
The company depends on pipeline prioritization, clinical validation, and the ability to unlock value from multiple programs.
Position Within the Biotechnology Landscape
Centessa is a platform biotech name whose valuation reflects optionality and execution across a portfolio of assets.
Future catalysts
- Centessa’s catalyst set is ORX750 and the broader orexin-agonist strategy, which could matter a lot if the sleep program continues to show a clean dose and efficacy profile. The next update is important because the market wants to know whether the orexin thesis can become a real franchise.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Centessa Pharmaceuticals (CNTA)?
Centessa Pharmaceuticals (CNTA) most recently closed at 40.50 USD, a +0.80% move versus the previous session.
What is the market cap of Centessa Pharmaceuticals (CNTA)?
Centessa Pharmaceuticals currently has a market capitalization of 6.17B USD on BioPharmSignal.
What does Centessa Pharmaceuticals do?
Centessa Pharmaceuticals is a platform biopharma company incubating focused therapeutic programs across multiple disease areas. Its model emphasizes capital allocation, program selection, and broad platform optionality.
On which exchange is CNTA stock listed?
Centessa Pharmaceuticals (CNTA) is associated with NASDAQ, United Kingdom, Biopharma.
What is Centessa?
Centessa’s catalyst set is ORX750 and the broader orexin-agonist strategy, which could matter a lot if the sleep program continues to show a clean dose and efficacy profile.
Which conditions is Centessa Pharmaceuticals targeting with Centessa?
Centessa’s catalyst set is ORX750 and the broader orexin-agonist strategy, which could matter a lot if the sleep program continues to show a clean dose and efficacy profile.
How does Centessa Pharmaceuticals describe recent progress with Centessa?
Centessa’s catalyst set is ORX750 and the broader orexin-agonist strategy, which could matter a lot if the sleep program continues to show a clean dose and efficacy profile.
What is Pharmaceuticals?
Centessa Pharmaceuticals is a platform biopharma company incubating focused therapeutic programs across multiple disease areas.